Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antifungal Agents”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00001810
What this trial is testing

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

Who this might be right for
AspergillosisCandidiasisFungemia+1 more
National Cancer Institute (NCI) 300
Post-approval studies (Phase 4)Ended earlyNCT00455364
What this trial is testing

Voriconazole as Prophylactic Therapy in Lung Transplant Recipients

Who this might be right for
Infection
University of Chicago 20
Testing effectiveness (Phase 2)Study completedNCT00000655
What this trial is testing

A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Not applicableStudy completedNCT04619147
What this trial is testing

Invasive Fungal Infections in Patients Following Stem Cell Transplant

Who this might be right for
Invasive Fungal InfectionsStem Cell Transplant Complications
Peter MacCallum Cancer Centre, Australia 300
Large-scale testing (Phase 3)Study completedNCT02145832
What this trial is testing

Fluconazole Versus Micafungin in Neonates With Candidiasis

Who this might be right for
Candidiasis
Institut National de la Santé Et de la Recherche Médicale, France 100
Not applicableLooking for participantsNCT05434104
What this trial is testing

The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study

Who this might be right for
Bacterial VaginosisCandida Vaginal
Guy's and St Thomas' NHS Foundation Trust 114
Post-approval studies (Phase 4)Not Yet RecruitingNCT06756191
What this trial is testing

Antifungal Drugs in Pulmonary Mucormycosis

Who this might be right for
Pulmonary Mucormycosis
Bin Cao 312
Early research (Phase 1)Ended earlyNCT02057289
What this trial is testing

A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis

Who this might be right for
ImmunocompromisedBone Marrow TransplantCancer
Children's Hospital Medical Center, Cincinnati 9
Large-scale testing (Phase 3)Study completedNCT00289991
What this trial is testing

Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)

Who this might be right for
Antifungal Prophylaxis of Invasive Fungal Infections
Pfizer 489
Large-scale testing (Phase 3)UnknownNCT05279846
What this trial is testing

A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

Who this might be right for
Onychomycosis
Moberg Pharma AB 350
Large-scale testing (Phase 3)Ended earlyNCT04707703
What this trial is testing

Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2Aspergillosis Invasive
Jeffrey Jenks, MD, MPH 8
Testing effectiveness (Phase 2)Study completedNCT00076869
What this trial is testing

MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)

Who this might be right for
Aspergillosis
Merck Sharp & Dohme LLC 55
Large-scale testing (Phase 3)Study completedNCT00000802
What this trial is testing

A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 700
Testing effectiveness (Phase 2)WithdrawnNCT02658292
What this trial is testing

Safety and Efficacy of NAFT900 in Children With Tinea Capitis

Who this might be right for
Tinea Capitis
Merz North America, Inc.
Post-approval studies (Phase 4)Ended earlyNCT00386997
What this trial is testing

ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Fungal Infection
Gilead Sciences 20
Testing effectiveness (Phase 2)Study completedNCT00000975
What this trial is testing

Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS

Who this might be right for
HIV InfectionsHistoplasmosis
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT02142153
What this trial is testing

F901318 Single Ascending Dose Study in Healthy Male Volunteers

Who this might be right for
Invasive Aspergillosis
F2G Ltd 40
Large-scale testing (Phase 3)Study completedNCT00748345
What this trial is testing

Pharmacokinetics of Caspofungin in Burn Patients

Who this might be right for
Thermal Injury
Assistance Publique - Hôpitaux de Paris 2
Large-scale testing (Phase 3)Study completedNCT00117754
What this trial is testing

Terbinafine Compared to Griseofulvin in Children With Tinea Capitis

Who this might be right for
Tinea Capitis
Novartis 720
Not applicableUnknownNCT04386031
What this trial is testing

Fungal Infection After Oral Cavity Surgeries

Who this might be right for
Prevalence of Fungal Infection in Patients Undergoing Oral Cavity Surgery Without Treatment With Antifungal Drug
Rambam Health Care Campus 80
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation